1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Biomarkers by Type
  • 1.3.1 Overview: Global Biomarkers Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Biomarkers Consumption Value Market Share by Type in 2025
  • 1.3.3 Sepsis Biomarkers
  • 1.3.4 Antibiotic Resistance Biomarkers
  • 1.3.5 Traumatic Brain Injury (TBI) Testing Biomarkers
  • 1.3.6 Stroke Testing Biomarkers
  • 1.3.7 Antibiotic Stewardship Biomarkers
  • 1.3.8 Other
• 1.4 Global Biomarkers Market by Application
  • 1.4.1 Overview: Global Biomarkers Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Diagnostics
  • 1.4.3 Drug Discovery
  • 1.4.4 Personalized Medicine
  • 1.4.5 Other
• 1.5 Global Biomarkers Market Size & Forecast
• 1.6 Global Biomarkers Market Size and Forecast by Region
  • 1.6.1 Global Biomarkers Market Size by Region: 2021 VS 2025 VS 2032
  • 1.6.2 Global Biomarkers Market Size by Region, (2021-2032)
  • 1.6.3 North America Biomarkers Market Size and Prospect (2021-2032)
  • 1.6.4 Europe Biomarkers Market Size and Prospect (2021-2032)
  • 1.6.5 Asia-Pacific Biomarkers Market Size and Prospect (2021-2032)
  • 1.6.6 South America Biomarkers Market Size and Prospect (2021-2032)
  • 1.6.7 Middle East & Africa Biomarkers Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Thermo Fisher Scientific
  • 2.1.1 Thermo Fisher Scientific Details
  • 2.1.2 Thermo Fisher Scientific Major Business
  • 2.1.3 Thermo Fisher Scientific Biomarkers Product and Solutions
  • 2.1.4 Thermo Fisher Scientific Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.2 Merck
  • 2.2.1 Merck Details
  • 2.2.2 Merck Major Business
  • 2.2.3 Merck Biomarkers Product and Solutions
  • 2.2.4 Merck Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Merck Recent Developments and Future Plans
• 2.3 Bio-Rad Laboratories
  • 2.3.1 Bio-Rad Laboratories Details
  • 2.3.2 Bio-Rad Laboratories Major Business
  • 2.3.3 Bio-Rad Laboratories Biomarkers Product and Solutions
  • 2.3.4 Bio-Rad Laboratories Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
• 2.4 QIAGEN
  • 2.4.1 QIAGEN Details
  • 2.4.2 QIAGEN Major Business
  • 2.4.3 QIAGEN Biomarkers Product and Solutions
  • 2.4.4 QIAGEN Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 QIAGEN Recent Developments and Future Plans
• 2.5 Roche
  • 2.5.1 Roche Details
  • 2.5.2 Roche Major Business
  • 2.5.3 Roche Biomarkers Product and Solutions
  • 2.5.4 Roche Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 Roche Recent Developments and Future Plans
• 2.6 Danaher Corporation
  • 2.6.1 Danaher Corporation Details
  • 2.6.2 Danaher Corporation Major Business
  • 2.6.3 Danaher Corporation Biomarkers Product and Solutions
  • 2.6.4 Danaher Corporation Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Danaher Corporation Recent Developments and Future Plans
• 2.7 Siemens Healthcare
  • 2.7.1 Siemens Healthcare Details
  • 2.7.2 Siemens Healthcare Major Business
  • 2.7.3 Siemens Healthcare Biomarkers Product and Solutions
  • 2.7.4 Siemens Healthcare Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 Siemens Healthcare Recent Developments and Future Plans
• 2.8 Abbott
  • 2.8.1 Abbott Details
  • 2.8.2 Abbott Major Business
  • 2.8.3 Abbott Biomarkers Product and Solutions
  • 2.8.4 Abbott Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 Abbott Recent Developments and Future Plans
• 2.9 Agilent Technologies
  • 2.9.1 Agilent Technologies Details
  • 2.9.2 Agilent Technologies Major Business
  • 2.9.3 Agilent Technologies Biomarkers Product and Solutions
  • 2.9.4 Agilent Technologies Biomarkers Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Agilent Technologies Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Biomarkers Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Biomarkers by Company Revenue
  • 3.2.2 Top 3 Biomarkers Players Market Share in 2025
  • 3.2.3 Top 6 Biomarkers Players Market Share in 2025
• 3.3 Biomarkers Market: Overall Company Footprint Analysis
  • 3.3.1 Biomarkers Market: Region Footprint
  • 3.3.2 Biomarkers Market: Company Product Type Footprint
  • 3.3.3 Biomarkers Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Biomarkers Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Biomarkers Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Biomarkers Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Biomarkers Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Biomarkers Consumption Value by Type (2021-2032)
• 6.2 North America Biomarkers Market Size by Application (2021-2032)
• 6.3 North America Biomarkers Market Size by Country
  • 6.3.1 North America Biomarkers Consumption Value by Country (2021-2032)
  • 6.3.2 United States Biomarkers Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Biomarkers Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Biomarkers Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Biomarkers Consumption Value by Type (2021-2032)
• 7.2 Europe Biomarkers Consumption Value by Application (2021-2032)
• 7.3 Europe Biomarkers Market Size by Country
  • 7.3.1 Europe Biomarkers Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Biomarkers Market Size and Forecast (2021-2032)
  • 7.3.3 France Biomarkers Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Biomarkers Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Biomarkers Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Biomarkers Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Biomarkers Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Biomarkers Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Biomarkers Market Size by Region
  • 8.3.1 Asia-Pacific Biomarkers Consumption Value by Region (2021-2032)
  • 8.3.2 China Biomarkers Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Biomarkers Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Biomarkers Market Size and Forecast (2021-2032)
  • 8.3.5 India Biomarkers Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Biomarkers Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Biomarkers Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Biomarkers Consumption Value by Type (2021-2032)
• 9.2 South America Biomarkers Consumption Value by Application (2021-2032)
• 9.3 South America Biomarkers Market Size by Country
  • 9.3.1 South America Biomarkers Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Biomarkers Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Biomarkers Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Biomarkers Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Biomarkers Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Biomarkers Market Size by Country
  • 10.3.1 Middle East & Africa Biomarkers Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Biomarkers Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Biomarkers Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Biomarkers Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Biomarkers Market Drivers
• 11.2 Biomarkers Market Restraints
• 11.3 Biomarkers Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Biomarkers Industry Chain
• 12.2 Biomarkers Upstream Analysis
• 12.3 Biomarkers Midstream Analysis
• 12.4 Biomarkers Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Biomarkers market size was valued at US$ 96030 million in 2025 and is forecast to a readjusted size of US$ 241730 million by 2032 with a CAGR of 14.3% during review period.
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
This report is a detailed and comprehensive analysis for global Biomarkers market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biomarkers market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biomarkers market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biomarkers market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biomarkers market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biomarkers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biomarkers market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, Agilent Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biomarkers market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Market segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
Market segment by players, this report covers
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biomarkers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biomarkers, with revenue, gross margin, and global market share of Biomarkers from 2021 to 2026.
Chapter 3, the Biomarkers competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biomarkers market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomarkers.
Chapter 13, to describe Biomarkers research findings and conclusion.